Design Therapeutics, Inc. (DSGN) vs Sana Biotechnology, Inc. (SANA)
A side-by-side comparison of Design Therapeutics, Inc. and Sana Biotechnology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DSGN
Design Therapeutics, Inc.
$11.97HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SANA
Sana Biotechnology, Inc.
$2.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — DSGN vs SANA
growth of $100 · dividends reinvested · last 6yDSGN -70.1% (-18.2%/yr)SANA -90.6% (-32.5%/yr)DSGN compounded faster over this window
DSGN SANA
DSGN vs SANA: by the numbers
- •SANA is the larger company ($765M vs $748M market cap).
Metrics side by side
Valuation
| Metric | DSGN | SANA |
|---|---|---|
| P/B ratio | 3.70 | 4.95 |
Profitability
| Metric | DSGN | SANA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -35.07% | -137.04% |
| ROIC | -38.92% | -67.58% |
Growth (annualized)
| Metric | DSGN | SANA |
|---|---|---|
| Total return CAGR (5Y) | -3.82% | -32.33% |
Frequently asked
- How have DSGN and SANA total returns compared?
- Over the past 5 years, DSGN delivered -3.82% and SANA delivered -32.33% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.